NEU neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-157

  1. 512 Posts.
    lightbulb Created with Sketch. 1650
    Interesting. Supports Trof being priced at a similar level of $350k+ you'd think. And helps to reinforce that Trof approval must be all but impossible not to occur.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.07
Change
0.220(1.71%)
Mkt cap ! $1.635B
Open High Low Value Volume
$13.15 $13.37 $12.92 $4.880M 371.9K

Buyers (Bids)

No. Vol. Price($)
7 157 $13.07
 

Sellers (Offers)

Price($) Vol. No.
$13.08 1355 10
View Market Depth
Last trade - 13.16pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.